• Je něco špatně v tomto záznamu ?

Clinically relevant copy-number variants in exome sequencing data of patients with dystonia

M. Zech, S. Boesch, M. Škorvánek, J. Necpál, J. Švantnerová, M. Wagner, Y. Dincer, A. Sadr-Nabavi, T. Serranová, I. Rektorová, P. Havránková, S. Ganai, A. Mosejová, I. Příhodová, J. Šarláková, K. Kulcsarová, O. Ulmanová, K. Bechyně, M....

. 2021 ; 84 (-) : 129-134. [pub] 20210212

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004593

INTRODUCTION: Next-generation sequencing is now used on a routine basis for molecular testing but studies on copy-number variant (CNV) detection from next-generation sequencing data are underrepresented. Utilizing an existing whole-exome sequencing (WES) dataset, we sought to investigate the contribution of rare CNVs to the genetic causality of dystonia. METHODS: The CNV read-depth analysis tool ExomeDepth was applied to the exome sequences of 953 unrelated patients with dystonia (600 with isolated dystonia and 353 with combined dystonia; 33% with additional neurological involvement). We prioritized rare CNVs that affected known disease genes and/or were known to be associated with defined microdeletion/microduplication syndromes. Pathogenicity assessment of CNVs was based on recently published standards of the American College of Medical Genetics and Genomics and the Clinical Genome Resource. RESULTS: We identified pathogenic or likely pathogenic CNVs in 14 of 953 patients (1.5%). Of the 14 different CNVs, 12 were deletions and 2 were duplications, ranging in predicted size from 124bp to 17 Mb. Within the deletion intervals, BRPF1, CHD8, DJ1, EFTUD2, FGF14, GCH1, PANK2, SGCE, UBE3A, VPS16, WARS2, and WDR45 were determined as the most clinically relevant genes. The duplications involved chromosomal regions 6q21-q22 and 15q11-q13. CNV analysis increased the diagnostic yield in the total cohort from 18.4% to 19.8%, as compared to the assessment of single-nucleotide variants and small insertions and deletions alone. CONCLUSIONS: WES-based CNV analysis in dystonia is feasible, increases the diagnostic yield, and should be combined with the assessment of single-nucleotide variants and small insertions and deletions.

1st Department of Neurology Faculty of Medicine St Anne's University Hospital and CEITEC Masaryk University Brno Czech Republic

2nd Department of Neurology Faculty of Medicine Comenius University University Hospital Bratislava Bratislava Slovakia

Academic Center for Education Culture and Research Khorasan Razavi Mashhad Iran

Department of Medical Genetics Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran

Department of Neurology Charles University 1st Faculty of Medicine and General University Hospital Prague Prague Czech Republic

Department of Neurology Faculty of Medicine Mashhad University of Medical Sciences Qaem Medical Center Mashhad Iran

Department of Neurology Hospital Písek Písek Czech Republic

Department of Neurology Medical University Innsbruck Innsbruck Austria

Department of Neurology P J Safarik University Kosice Slovak Republic

Department of Neurology University Hospital Hradec Kralove Hradec Králové Czech Republic

Department of Neurology University Hospital of L Pasteur Kosice Slovak Republic

Department of Neurology Zvolen Hospital Slovakia

Institute of Human Genetics Technical University of Munich Munich Germany

Institute of Neurogenomics Helmholtz Zentrum München Munich Germany

Institute of Neuropathology and Department of Neurosurgery University Medical Center Göttingen Göttingen Germany

Kbo Kinderzentrum München Munich Germany

Klinik und Poliklinik für Neurologie Klinikum Rechts der Isar Technische Universität München Munich Germany

Lehrstuhl für Neurogenetik Technische Universität München Munich Germany

Lehrstuhl für Sozialpädiatrie Technische Universität München Munich Germany

Munich Cluster for Systems Neurology SyNergy Munich Germany

Paracelsus Elena Klinik Kassel Germany

Schön Klinik München Schwabing Munich Germany

Zentrum für Humangenetik und Laboratoriumsdiagnostik Martinsried Germany

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004593
003      
CZ-PrNML
005      
20241120155734.0
007      
ta
008      
220113e20210212xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.parkreldis.2021.02.013 $2 doi
035    __
$a (PubMed)33611074
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Zech, Michael $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany; Institute of Human Genetics, Technical University of Munich, Munich, Germany. Electronic address: michael.zech@mri.tum.de
245    10
$a Clinically relevant copy-number variants in exome sequencing data of patients with dystonia / $c M. Zech, S. Boesch, M. Škorvánek, J. Necpál, J. Švantnerová, M. Wagner, Y. Dincer, A. Sadr-Nabavi, T. Serranová, I. Rektorová, P. Havránková, S. Ganai, A. Mosejová, I. Příhodová, J. Šarláková, K. Kulcsarová, O. Ulmanová, K. Bechyně, M. Ostrozovičová, V. Haň, JR. Ventosa, M. Shariati, A. Shoeibi, S. Weber, B. Mollenhauer, C. Trenkwalder, R. Berutti, TM. Strom, A. Ceballos-Baumann, V. Mall, B. Haslinger, R. Jech, J. Winkelmann
520    9_
$a INTRODUCTION: Next-generation sequencing is now used on a routine basis for molecular testing but studies on copy-number variant (CNV) detection from next-generation sequencing data are underrepresented. Utilizing an existing whole-exome sequencing (WES) dataset, we sought to investigate the contribution of rare CNVs to the genetic causality of dystonia. METHODS: The CNV read-depth analysis tool ExomeDepth was applied to the exome sequences of 953 unrelated patients with dystonia (600 with isolated dystonia and 353 with combined dystonia; 33% with additional neurological involvement). We prioritized rare CNVs that affected known disease genes and/or were known to be associated with defined microdeletion/microduplication syndromes. Pathogenicity assessment of CNVs was based on recently published standards of the American College of Medical Genetics and Genomics and the Clinical Genome Resource. RESULTS: We identified pathogenic or likely pathogenic CNVs in 14 of 953 patients (1.5%). Of the 14 different CNVs, 12 were deletions and 2 were duplications, ranging in predicted size from 124bp to 17 Mb. Within the deletion intervals, BRPF1, CHD8, DJ1, EFTUD2, FGF14, GCH1, PANK2, SGCE, UBE3A, VPS16, WARS2, and WDR45 were determined as the most clinically relevant genes. The duplications involved chromosomal regions 6q21-q22 and 15q11-q13. CNV analysis increased the diagnostic yield in the total cohort from 18.4% to 19.8%, as compared to the assessment of single-nucleotide variants and small insertions and deletions alone. CONCLUSIONS: WES-based CNV analysis in dystonia is feasible, increases the diagnostic yield, and should be combined with the assessment of single-nucleotide variants and small insertions and deletions.
650    _2
$a dospělí $7 D000328
650    _2
$a kohortové studie $7 D015331
650    12
$a variabilita počtu kopií segmentů DNA $x genetika $7 D056915
650    _2
$a dystonie $x diagnóza $x genetika $7 D004421
650    _2
$a dystonické poruchy $x diagnóza $x genetika $7 D020821
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a sekvenování exomu $7 D000073359
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Boesch, Sylvia $u Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
700    1_
$a Škorvánek, Matej $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic; Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic
700    1_
$a Necpál, Ján $u Department of Neurology, Zvolen Hospital, Slovakia
700    1_
$a Švantnerová, Jana $u Second Department of Neurology, Faculty of Medicine, Comenius University, University Hospital Bratislava, Bratislava, Slovakia
700    1_
$a Wagner, Matias $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany; Institute of Human Genetics, Technical University of Munich, Munich, Germany
700    1_
$a Dincer, Yasemin $u Lehrstuhl für Sozialpädiatrie, Technische Universität München, Munich, Germany; Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ), Martinsried, Germany
700    1_
$a Sadr-Nabavi, Ariane $u Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Qaem Medical Center, Mashhad, Iran; Academic Center for Education, Culture and Research (ACECR)-Khorasan Razavi, Mashhad, Iran
700    1_
$a Serranová, Tereza $u Department of Neurology, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Rektorová, Irena $u First Department of Neurology, Faculty of Medicine, St. Anne's University Hospital and CEITEC, Masaryk University, Brno, Czech Republic
700    1_
$a Havránková, Petra $u Department of Neurology, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Ganai, Shahzaman $u Department of Neurology, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Lacková, Alexandra, $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic; Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic $d 1993- $7 xx0273781
700    1_
$a Příhodová, Iva $u Department of Neurology, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Šarláková, Jana $u Department of Neurology, University Hospital Hradec Kralove, Hradec Králové, Czech Republic
700    1_
$a Kulcsarová, Kristína $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic; Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic
700    1_
$a Ulmanová, Olga $u Department of Neurology, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Bechyně, Karel $u Department of Neurology, Hospital Písek, Písek, Czech Republic $7 xx0325752
700    1_
$a Ostrozovičová, Miriam $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic; Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic
700    1_
$a Haň, Vladimír $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic; Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic
700    1_
$a Ventosa, Joaquim Ribeiro $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic; Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic
700    1_
$a Shariati, Mohammad $u Department of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Qaem Medical Center, Mashhad, Iran; Academic Center for Education, Culture and Research (ACECR)-Khorasan Razavi, Mashhad, Iran
700    1_
$a Shoeibi, Ali $u Department of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Qaem Medical Center, Mashhad, Iran
700    1_
$a Weber, Sandrina $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany; Paracelsus-Elena-Klinik, Kassel, Germany
700    1_
$a Mollenhauer, Brit $u Paracelsus-Elena-Klinik, Kassel, Germany; Institute of Neuropathology and Department of Neurosurgery, University Medical Center Göttingen, Göttingen, Germany
700    1_
$a Trenkwalder, Claudia $u Paracelsus-Elena-Klinik, Kassel, Germany; Institute of Neuropathology and Department of Neurosurgery, University Medical Center Göttingen, Göttingen, Germany
700    1_
$a Berutti, Riccardo $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany; Institute of Human Genetics, Technical University of Munich, Munich, Germany
700    1_
$a Strom, Tim M $u Institute of Human Genetics, Technical University of Munich, Munich, Germany
700    1_
$a Ceballos-Baumann, Andres $u Schön Klinik München Schwabing, Munich, Germany
700    1_
$a Mall, Volker $u Lehrstuhl für Sozialpädiatrie, Technische Universität München, Munich, Germany; Kbo-Kinderzentrum München, Munich, Germany
700    1_
$a Haslinger, Bernhard $u Klinik und Poliklinik für Neurologie, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany
700    1_
$a Jech, Robert $u Department of Neurology, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Winkelmann, Juliane $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany; Institute of Human Genetics, Technical University of Munich, Munich, Germany; Lehrstuhl für Neurogenetik, Technische Universität München, Munich, Germany; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany
773    0_
$w MED00006198 $t Parkinsonism & related disorders $x 1873-5126 $g Roč. 84 (20210212), s. 129-134
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33611074 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20241120155728 $b ABA008
999    __
$a ok $b bmc $g 1751907 $s 1155742
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 84 $c - $d 129-134 $e 20210212 $i 1873-5126 $m Parkinsonism & related disorders $n Parkinsonism Relat Disord $x MED00006198
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...